4
Changes in Ownership
Viridian Therapeutics, Inc.\DE Filed Acc 0000950170-23-057692
Options or other derivatives
- Director acquired 48,463 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Fairmount Funds Management LLC Director | 2023-10-30 | Grant or award · Series B Non-Voting Convertible Preferred Stock | +48,463 | $825.37 | $40,000,129 | 48,463 | I |
Loading xslF345X05/ownership.xml…